MétaCan
Menu
Back to cohort
Record W2005557489 · doi:10.1186/s13058-015-0522-2

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

2015· review· en· W2005557489 on OpenAlexafffund
Jieping Lei, Anja Rudolph, Kirsten B. Moysich, Sajjad Rafiq, Sabine Behrens, Ellen L. Goode, Paul D.P. Pharoah, Petra Seibold, Peter A. Fasching, Irene L. Andrulis, Vessela N. Kristensen, Fergus J. Couch, Ute Hamann, Maartje J. Hooning, Heli Nevanlinna, Ursula Eilber, Manjeet K. Bolla, Joe Dennis, Qin Wang, Annika Lindblom, Diether Lambrechts, Montserrat García‐Closas, Per Hall, Georgia Chenevix‐Trench, Mitul Shah, Robert Luben, Lothar Haeberle, Arif B. Ekici, Matthias W. Beckmann, Julia A. Knight, Gord Glendon, Sandrine Tchatchou, Grethe I.G. Alnæs, Anne‐Lise Børresen‐Dale, Silje Nord, Janet E. Olson, Emily Hallberg, Celine M. Vachon, Diana Torres, Hans-Ulrich Ulmer, Thomas Rüdiger, Agnes Jager, Madeleine MA Tilanus-Linthorst, Taru Muranen, Kristiina Aittomäki, Carl Blomqvist, Sara Margolin, Veli‐Matti Kosma, Jaana M. Hartikainen, Vesa Kataja, Sigrid Hatse, Hans Wildiers, Ann Smeets, Jonine D. Figueroa, Stephen J. Chanock, Jolanta Lissowska, Jingmei Li, Keith Humphreys, Kelly‐Anne Phillips, Sabine C. Linn, Sten Cornelissen, Sandra Alexandra J van den Broek, Daehee Kang, Ji‐Yeob Choi, Sue K. Park, Keun-Young Yoo, Chia‐Ni Hsiung, Pei‐Ei Wu, Ming‐Feng Hou, Chen‐Yang Shen, Soo‐Hwang Teo, Nur Aishah Mohd Taib, Cheng Har Yip, Gwo Fuang Ho, Keitaro Matsuo, Hidemi Ito, Hiroji Iwata, Kazuo Tajima, Alison M. Dunning, Javier Benı́tez, Kamila Czene, Lara E. Sucheston, Tom Maishman, William Tapper, Diana Eccles, Douglas F. Easton, Marjanka K. Schmidt, Jenny Chang‐Claude

Bibliographic record

VenueBreast Cancer Research · 2015
Typereview
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicTGF-β signaling in diseases
Canadian institutionsCanada Research ChairsLunenfeld-Tanenbaum Research InstitutePublic Health OntarioUniversity of TorontoMount Sinai Hospital
FundersNational Cancer InstituteMedisinske fakultet, Universitetet i OsloInstitute of Biomedical Sciences, Academia SinicaBiomedical Research CouncilDeutsche KrebshilfeNorges ForskningsrådUniversitetet i OsloSingapore Eye Research InstituteStockholms Läns LandstingAcademia SinicaKuopion Yliopistollinen SairaalaKarolinska InstitutetMedical Research CouncilNational Research Foundation of KoreaNational Health and Medical Research CouncilNational Medical Research CouncilMinistério da Ciência, Tecnologia e InovaçãoU.S. Department of Health and Human ServicesHaukeland UniversitetssjukehusNederlandse Organisatie voor Wetenschappelijk OnderzoekAgency for Science, Technology and ResearchBundesministerium für Bildung und ForschungMinistry of Education, Science and TechnologyOvarian Cancer Research FundCancer AustraliaNational Research FoundationNational Institute for Health and Care ResearchCanadian Institutes of Health ResearchCancerfondenNIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer ResearchBreast Cancer CampaignAkershus UniversitetssykehusFrancis Crick InstituteNational Institutes of HealthDavid F. and Margaret T. Grohne Family FoundationDeutsches KrebsforschungszentrumUniversitetet i BergenGénome QuébecKementerian Sains, Teknologi dan InovasiSusan G. KomenHelsingin ja Uudenmaan SairaanhoitopiiriTaiwan BiobankItä-Suomen YliopistoEuropean CommissionUniversity of CambridgeMcGill UniversityBreast Cancer Research FoundationNational Breast Cancer FoundationUniversitetet i TromsøKWF KankerbestrijdingCancer Research UK
KeywordsBreast cancerOncologyInternal medicineHazard ratioMedicineEstrogen receptorChemotherapySingle-nucleotide polymorphismProportional hazards modelCancerSurgical oncologyConfidence intervalBiologyGeneGenotypeGenetics

Abstract

fetched live from OpenAlex

INTRODUCTION: Tumor lymphocyte infiltration is associated with clinical response to chemotherapy in estrogen receptor (ER) negative breast cancer. To identify variants in immunosuppressive pathway genes associated with prognosis after adjuvant chemotherapy for ER-negative patients, we studied stage I-III invasive breast cancer patients of European ancestry, including 9,334 ER-positive (3,151 treated with chemotherapy) and 2,334 ER-negative patients (1,499 treated with chemotherapy). METHODS: We pooled data from sixteen studies from the Breast Cancer Association Consortium (BCAC), and employed two independent studies for replications. Overall 3,610 single nucleotide polymorphisms (SNPs) in 133 genes were genotyped as part of the Collaborative Oncological Gene-environment Study, in which phenotype and clinical data were collected and harmonized. Multivariable Cox proportional hazard regression was used to assess genetic associations with overall survival (OS) and breast cancer-specific survival (BCSS). Heterogeneity according to chemotherapy or ER status was evaluated with the log-likelihood ratio test. RESULTS: Three independent SNPs in TGFBR2 and IL12B were associated with OS (P <10⁻³) solely in ER-negative patients after chemotherapy (267 events). Poorer OS associated with TGFBR2 rs1367610 (G > C) (per allele hazard ratio (HR) 1.54 (95% confidence interval (CI) 1.22 to 1.95), P = 3.08 × 10⁻⁴) was not found in ER-negative patients without chemotherapy or ER-positive patients with chemotherapy (P for interaction <10-3). Two SNPs in IL12B (r² = 0.20) showed different associations with ER-negative disease after chemotherapy: rs2546892 (G > A) with poorer OS (HR 1.50 (95% CI 1.21 to 1.86), P = 1.81 × 10⁻⁴), and rs2853694 (A > C) with improved OS (HR 0.73 (95% CI 0.61 to 0.87), P = 3.67 × 10⁻⁴). Similar associations were observed with BCSS. Association with TGFBR2 rs1367610 but not IL12B variants replicated using BCAC Asian samples and the independent Prospective Study of Outcomes in Sporadic versus Hereditary Breast Cancer Study and yielded a combined HR of 1.57 ((95% CI 1.28 to 1.94), P = 2.05 × 10⁻⁵) without study heterogeneity. CONCLUSIONS: TGFBR2 variants may have prognostic and predictive value in ER-negative breast cancer patients treated with adjuvant chemotherapy. Our findings provide further insights into the development of immunotherapeutic targets for ER-negative breast cancer.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Other design · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.853
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.053
GPT teacher head0.409
Teacher spread0.356 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designOther design
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations24
Published2015
Admission routes2
Has abstractyes

Explore more

Same venueBreast Cancer ResearchSame topicTGF-β signaling in diseasesFrench-language works237,207